Drug info - Qh-ii-66 - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > CHEMICAL & (SEMI-) SYNTHETIC DRUGS > Research Chemicals
Register Tags Mark Forums Read

Notices

Research Chemicals Piperazines, Phenethylamines, Tryptamines & other Research Chemicals or designer drugs.

Reply
 
Thread Tools Display Modes
  #1  
Old 25-11-2008, 16:04
0utrider's Avatar
0utrider 0utrider is offline
0utrider is is singing in the rain
Palladium MemberDonating
 
Join Date: 06-06-2007
Location: here and there...
Posts: 1,383
Blog Entries: 8
0utrider really knows their shit.0utrider really knows their shit.0utrider really knows their shit.0utrider really knows their shit.0utrider really knows their shit.0utrider really knows their shit.0utrider really knows their shit.0utrider really knows their shit.0utrider really knows their shit.0utrider really knows their shit.
Points: 18,883, Level: 19 Points: 18,883, Level: 19 Points: 18,883, Level: 19
Activity: 5% Activity: 5% Activity: 5%
Qh-ii-66

Please post info about QH-II-66 here.
Can anyone add information about:
  • names / synonyms
  • molecule
  • dose
  • duration
  • side effects
  • have there been any reported incidents with this compound?
  • since when has this research chemical been available?
  • legal status
  • stability of the molecule / compound
Experiences should be posted here: http://www.drugs-forum.co.uk/forum/s...617#post501617

Quote:
QH-II-66 (QH-ii-066) is a sedative drug which is a benzodiazepine derivative.[1] It produces some of the same effects as other benzodiazepines, but is much more selective than most other drugs of this class and so produces somewhat less sedation and ataxia than other related drugs such as diazepam and triazolam, although it still retains anticonvulsant effects.[2]
QH-ii-066 is a highly subtype-selective GABAA agonist which was designed to bind selectively to the α5 subtype of GABAA receptors.[3]
The α5 subtype (and to a lesser extent the α1 subtype) of GABAA are two of the most important targets in the brain that produce the effects of alcohol,[4] and so one of the purposes for which QH-ii-066 was developed was to reproduce the GABAergic effects of alcohol separately from its other actions.[5]
QH-ii-066 replicates some of the effects of alcohol, such as sedation and ataxia, but does not increase appetite, as this effect seems to be produced by the α1 subtype of GABAA rather than α5.[6] It is also interesting to note that the inverse agonist Ro15-4513, which blocks the α4 subtype of GABAA, reverses the effects of alcohol, suggesting that this subtype is also important in producing the subjective effects of alcohol intoxication.[7]
Reply With Quote
Reply

Bookmarks

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


Sitelinks: Site Functions:

All times are GMT +1. The time now is 04:25.


Copyright: Substance Information Network 2003 - 2009, All rights reserved